OBJECTIVE: To examine the factors associated with liver steatosis in severely obese subjects and to test the potential reversibility of fatty liver after weight loss. DESIGN: Retrospective clinical study. SUBJECT: 528 obese patients before bariatric surgery and 69 obese subjects of the initial cohort evaluated before and 27 AE 15 months after gastroplasty. MEASUREMENTS: Fatty deposition (scored as mild, moderate or severe) and in¯ammatory changes were evaluated in liver biopsies; clinical (body mass index (BMI), age, gender, duration of obesity) and biological (glucose, triglycerides, liver enzymes) parameters were related to histological ®ndings. RESULTS: 74% of the 528 biopsies showed fatty change, estimated as mild in 41% of cases, moderate in 32% and severe in 27%. The prevalence of steatosis was signi®cantly higher in men than in women (91% vs 70%, P 0.001) and in patients with impaired glucose tolerance or type 2 diabetes compared with nondiabetics (89% vs 69% P 0.001). The severity of the steatosis was associated with BMI (P 0.002) but not with the duration of obesity or the age of the patient. When compared with patients without fatty change, those with liver steatosis had signi®cantly higher fasting plasma glucose (5.5 mmol/l vs 5.1 mmol/l, P 0.007) and triglycerides (1.8 mmol/l vs 1.3 mmol/l, P 0.002). Mean serum liver enzyme activities (alkaline phosphatase, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyl-transpeptidase (gGT) were signi®cantly (P`0.001) increased in patients with fatty change but remained within laboratory reference values. In the 69 patients who have been evaluated after a marked weight reduction (732 AE 19 kg), 45% of the biopsies were considered as normal (vs 13% before, P`0.001) while pure fatty change was still observed in 38% of the patients (vs 83% before, P 0.001). However, the severity of the steatosis was signi®cantly (P`0.001) reduced (mild: 62% vs 21%; moderate: 23% vs 37%; severe: 15% vs 42%). In addition, a signi®cant increase of hepatitis was observed in 26% of the biopsies (vs 14% before, P`0.05). CONCLUSIONS: Liver steatosis in obese subjects is associated with men, diabetic status, BMI, higher fasting glucose and hypertriglyceridaemia. Postgastroplasty weight loss reduces liver steatosis, but seems to increase the incidence of in¯ammatory lobular hepatitis.
Introduction
Patients with metabolic disorders, such as obesity or diabetes mellitus, frequently develop`liver steatosis', a pathology characterized by the deposition of large fat droplets in the hepatic parenchymal cells. 1±3 In obese subjects, the enhanced rate of lipolysis leads to an increased availability of free fatty acids responsible for an exaggerated synthesis and deposition of triglycerides in the hepatocytes. 4, 5 Mild-to-moderate liver steatosis shows a predilection for centrilobular distribution, progressing to diffuse fatty accumulation when massive. More severe abnormalities may occur such as`nonalcoholic steatohepatitis' or`fatty liver hepatitis', which mimics the spectrum of alcoholic hepatitis and may eventually progress to ®brosis and even cirrhosis. 6 In this retrospective study, we ®rst examined the liver biopsies of a large cohort of severely obese patients. We then looked for correlation between the severity of fatty change in the liver and various physiological, pathological and biological parameters.
In order to better evaluate the role of obesity in causing liver disease and to appreciate the potential reversibility of established liver abnormalities, we compared the histological status of the liver of 69 severely obese patients before and after gastroplastyinduced weight loss.
Materials and methods

Subjects
The ®rst part of this study was retrospectively performed on clinical records from 528 severely obese (body mass index (BMI) 44.9 AE 7.1 kg/m 2 ) patients submitted to a vertical ring gastroplasty 7 or an adjustable gastric banding. 8 Each patient was evaluated by a multidisciplinary team, including specialists in inter-nal medicine, psychiatrists and dietitians, and considered eligible for surgery if he/she presented severe or morbid obesity, resistance to classic dietary and pharmacologic treatments and/or associated comorbid conditions. Insuf®ciently motivated patients, alcohol abusers (b 20 glasses/week) or drug addicts were excluded. Of the selected subjects, 17% had either impaired glucose tolerance (IGT) or type 2 diabetes.
The second part of this study was performed on 69 patients of the previous cohort (10 males and 59 females, aged 36 AE 11 y, BMI: 43.9 AE 8.3 kg/m 2 ), who had a second liver biopsy after gastroplasty, in the course of a mandatory surgical procedure (revision for staple line disruption, stenosis, pouch enlargement, slipping stomach, cholecystectomy, etc.). A possible selection-bias related to re-biopsy cannot be de®nitely excluded. However, mean weight loss in the subgroup submitted to a re-biopsy was nearly identical to mean weight loss of the overall population (732 AE 16 kg for the 528 patients at 26 AE 14 months, vs 732 AE 19 kg for the sub-sample of the 69 re-biopsied patients at 27 AE 15 months).
Informed consent was obtained before performing liver biopsy.
Anthropometric and laboratory data
Height and weight were measured by the hospital staff the day before surgery. Blood for measurement of biological parameters was obtained prior to surgery after an overnight fast. All the clinical chemistry determinations were carried out on an Auto-Analyzer AU 5000 (Olympus, Japan) following routine analysis methods. In this retrospective study, biochemical data were only available in about 60% of the population. Clinical characteristics (gender ratio, age, BMI, weight loss) were not signi®cantly different in the group of subjects with available biological data and in the group of subjects with no available biological data.
Histologic grading of the liver
A little wedge of liver was excised intraoperatively and ®xed in phosphate-buffered 10% formalin solution. Paraf®n block sections were cut at intervals of 5 mm. Sections were stained with hematoxylin and eosin, Masson's Trichrome and periodic acid-Schiff (PAS) according to standard procedures. All liver biopsies were examined blind, by the same team of pathologists. The parameters analyzed included the presence, severity, type and localization of fat, the presence and grade of steatohepatitis and the presence or absence of ®brosis and cirrhosis. The severity of liver steatosis was scored as`mild' if`33% of parenchyma was involved (grade 1),`moderate' when steatosis occurred in 33±66% of the hepatocytes (grade 2), and`severe' fatty change when b 66% of hepatocytes had fatty vacuolization. The severity of hepatitis was scored as mild (necrosis of individual hepatocytes with focal accumulation of polymorphonuclear leucocytes), moderate (more widespread hepatocellular degeneration and polymorphonuclear leucocytes accumulating in clumps) and severe (massive necrosis of liver cell plates with signi®cant lobular distortion).
Statistical methods
Means and standard deviations (s.d.) were calculated for age, BMI and biological parameters. Frequency distribution was calculated for each of the liver disturbance classes. Analysis of variance (ANOVA) was used to investigate the association between several constants and the grade of steatosis. Comparison of biological data was performed by Student's t test, 9 while comparison of the percentage of abnormalities in each group was performed using a Chi-square test. 9 Changes in distribution of histological ®ndings after weight loss were analyzed by a Chi-square test 9 for paired samples. All analyses and data management were performed using Statistical Analysis System (SAS, version 6.11). 10 
Results
Anthropometric data of the 528 patients explored in the ®rst part of the study are given in Table 1 . Means (AE) s.d.s are presented for age, BMI, excess body weight 11 and percentage of overweight. In Table 2 , we report the liver histological data at the time of the gastroplasty. Of the subjects, 21% had normal liver histology. Of biopsies, 74% showed fat in®ltration, accompanied by in¯ammatory changes in 10% of the original total. Among the patients with hepatitis, in¯ammatory changes were scored as mild in 86%, moderate in 12% and severe in 2%. Severe liver damage such as ®brosis or cirrhosis was extremely rare, probably due to the previous exclusion of alcoholic subjects from bariatric surgery.
Fatty change was estimated as mild in 41%, moderate in 32% and severe in 27% of the biopsies. Despite similar weight excess in both genders (Table  1) , prevalence of liver steatosis was signi®cantly higher in males than in females (91% vs 74%, P`0.001), but severity, type (predominantly macrovesicular steatosis) and localization (frequently centrilobular) of fat deposition were similar. The higher Liver diseases after weight loss FH Luyckx et al prevalence of liver steatosis in males vs females may be related to slightly but signi®cantly higher levels of fasting plasma glucose, serum triglycerides, alanine amino transferase (ALT) and gamma-glutamyl-transpeptidase (gGT) levels. A positive association was noticed between the presence of fatty change and IGT or type 2 diabetes: 89% of IGT and type 2 diabetes patients demonstrated fatty change compared to 69% of the normoglycaemic patients (P`0.001). The severity of steatosis, scored as grade 1, 2 and 3, was signi®cantly associated with BMI (P 0.002), but not with the known duration of obesity nor with the age at the time of gastroplasty (Table 3) . Clinical chemistry parameters were routinely measured in the blood of patients before surgery. As shown in Table 4 , the mean values were within the normal range values of the laboratory for all the parameters except cholesterol, which was slightly above the upper limit. The patients with liver steatosis had signi®cantly increased levels of glucose, triglycerides, alkaline phosphatase, aspartate aminotransferase (AST), ALT and gGT as compared to those with normal liver biopsies.
In addition, in order to determine an association between the severity of the steatosis and the degree of alteration of the biological parameters, we calculated the prevalence (%) of abnormal laboratory data in the previously de®ned groups of patients (Table 5) . Except for total cholesterol and alkaline phosphatase, a signi®cant increase in the percentage of results over the upper limits of normal values was observed for all the other parameters along with the worsening of fatty liver damage. ALT activity was particularly increased, suggesting a greater sensitivity of this enzyme in detecting fatty liver steatosis in severely obese patients.
The second part of this study was performed on 69 patients of the previous cohort, who had a follow-up liver biopsy 27 AE 15 months after gastroplasty in the course of new abdominal surgery. At this time, the mean weight loss averaged 32 AE 19 kg and mean BMI decreased from 43.9 AE 8.3 kg/m 2 to 31.7 AE 4.1 kg/m 2 (P`0.001).
The histological ®ndings before and after weight loss are given in Table 6 . After the drastic weight reduction induced by the gastroplasty, 45% of the histological observations were considered as normal. Fatty change occurred in 38% of the patients (vs 83% before, P`0.001). Furthermore, the severity of steatosis was signi®cantly (P`0.001) reduced in most cases: mild in 62% vs 21%, moderate in 23% vs 37% and severe in 15% vs 42% after and before weight loss, respectively. Improvements of liver changes were associated with signi®cant decrease in plasma glucose, serum triglycerides, total cholesterol and ALT (P`0.05). However, a signi®cant increase in hepatitis was observed (in 26% of the patients vs 14% before gastroplasty, P`0.05). Nevertheless, 87.5% of the cases were graded as mild, 12.5% as moderate and no severe hepatitis was observed. Prevalence of ®brosis and cirrhosis was unchanged. The sum of the percentages may be over 100% because some biopsies with steatosis also showed signs of hepatitis, ®brosis or cirrhosis. 
Alk. phosphatase alkaline phosphatase; AST aspartate aminotransferase; ALT alanine aminotransferase; gGT gamma-glutamyl-transpeptidase. NS Not statistically signi®cant.
Discussion
Among the many aetiologies of fatty change, alcohol, obesity, diabetes, drug toxicity and malnutrition are the most common. In severely obese patients without previous history of alcoholism or drug toxicity, the pathogenic factors contributing to liver steatosis are mainly an increased mobilization of lipids from expanded peripheral fat depots, combined with an increased synthesis and a decreased oxidation of fatty acids by the hepatocytes. In the absence of preexisting ®brosis or in¯ammation, the fatty change of non-alcoholic origin has been reported to be nonprogressive and benign. 12 However, follow-up studies of individuals with fatty liver have shown that, occasionally, steatosis could be associated with serious complications such as steatohepatitis, portal ®brosis and cirrhosis. 13 These severe hepatic damages may be explained by an increased lipid peroxidation linked to enhanced concentration of fat in the liver. 14 Our retrospective study on a large cohort of markedly obese subjects showed, as reported by others 1, 4 , that steatosis was the most frequent histological ®nd-ing and that it occurred more frequently in males than in females. Surprisingly, severe histological damage such as ®brosis or cirrhosis was extremely rare in our study, probably due to the selection criteria of our bariatric surgery candidates which excluded heavy drinkers. Steatosis was also signi®cantly more frequent in obese patients with IGT and type 2 diabetes, con®rm-ing the work of other groups. 15, 16 One of the mechanisms involved in the development of liver steatosis is the lower insulin sensitivity frequently observed in overweight patients. 17, 18 Diabetes mellitus also contributes to the enhanced rate of lipolysis in the adipose tissue, a metabolic pathway normally suppressed by insulin. Although some authors have found no association between the degree of obesity and the severity of fatty metamorphosis, 4 the prevalence and severity of fatty changes in other series, 19±21 as in ours, were positively associated with BMI. It seems that the association of biochemical test results and liver morphology in obesity greatly depends on the selection of obese patients. 13, 22 Our results demonstrated a signi®cant relationship between the increase of several biological parameters (glucose, triglycerides, AST, ALT, gGT) and liver fatty changes, particularly when severe fat deposition was present. However, fatty liver disease can be observed despite normal serum liver enzyme levels.
In addition, we evaluated the changes in liver microscopic morphology after a rapid and considerable weight loss, inducing recovery of a nearly normal body weight in some of our patients. Our group previously demonstrated that recovery of ideal body weight after gastroplasty is associated with a normalization of glucose and insulin metabolism. 23 The result of the present study indicated that weight reduction can lead to regression of fatty change in a majority of severely obese patients. However, it seems that the rapid weight loss induced by gastroplasty may sometimes precipitate mild lobular hepatitis in others. This suggests that the rapid mobilization of intra-and extrahepatic fat stores, probably associated in some cases with de®cient protein diet during weight loss, may contribute to the aggravation of preexistent liver steatosis in these subjects. 20, 24 Liver insults by hepatotoxic drugs, moderate alcohol intake or viral infections are retrospectively dif®cult to exclude and may explain part of the in¯ammatory changes observed in the second liver biopsy. Nevertheless, when hepatitis was present, a further investigation was performed on the liver fragment in most cases. CMV infection was excluded by in situ hybridisation while HBV and HCV infections were excluded by immunohistological techniques. Finally, in accordance with previous stu- Liver diseases after weight loss FH Luyckx et al dies, 5, 13 our data suggested that if several biological tests can be useful for the evaluation of the liver steatosis before and after weight loss in severely obese subjects, determination of plasma ALT is probably the most sensitive routine test to estimate the liver fatty change in this particular population.
In conclusion, the present study clearly shows that steatosis is the most prevalent histological liver abnormality in severely obese subjects. Marked weight loss induced by gastroplasty leads to regression of fatty change in most patients, but seems to slightly increase the incidence of in¯ammatory lobular hepatitis.
